If you got here after a late-night scroll through forums, TikTok and three different people telling you three different things, welcome. Let’s slow it down and start at the beginning.
Peptides in 60 seconds
- A peptide is a short chain of amino acids, the same building blocks that make up proteins.
- Your body makes them as messengers. Each one fits a specific receptor, like a key in a lock, and tells a cell what to do.
- They are everywhere in the news because peptide drugs for weight loss delivered some of the biggest results ever seen in large trials.
- Most peptides are broken down when swallowed, which is why so many come as injections.
- “Peptides” covers approved medicines, food ingredients and research compounds. They are very different things.
What is a peptide?
A peptide is a short chain of amino acids. The usual rule of thumb is two to fifty. String more together and you have a protein. Insulin, at 51, sits right on the line and is still called a peptide hormone.

Your body makes a huge range of them, and uses them mostly as messages. That one idea explains most of what follows.
How do peptides work?
Think of a peptide as a message and a cell as a locked door. The surface of a cell is dotted with receptors, each shaped to fit particular molecules. When the right peptide fits, the receptor passes a signal inside the cell, and the cell responds.
A few examples your own body runs on:
- Insulin tells your cells to take sugar out of the blood.
- GLP-1 is released from your gut after a meal. It tells your pancreas to release insulin and tells your brain you have had enough.
- Growth hormone releasing hormone (GHRH) tells your pituitary gland to release growth hormone.
Because each peptide fits its own lock, a well-designed one can be very selective, and reviews usually list specificity, potency and low toxicity as the big attractions for drug developers. The catch is delivery, which we get to below.
Why is everyone talking about peptides now?
Three things came together.
1. The weight-loss results
In the STEP 1 trial, 1,961 adults on semaglutide lost an average of 14.9% of their body weight over 68 weeks, against 2.4% on placebo. In SURMOUNT-1, the highest dose of tirzepatide averaged 20.9% over 72 weeks. Both are peptide drugs that copy gut hormones. In 2023 the journal Science named GLP-1 drugs its Breakthrough of the Year.
2. Better engineering
Natural GLP-1 lasts only about one to two minutes in your blood. Drug designers changed it so enzymes cannot cut it as easily and so it clings to proteins in the blood. Semaglutide’s half-life is about a week, around 165 hours in one trial, which is why it is a weekly pen and not a drip.
3. A pipeline that keeps going
Estimates of approved peptide drugs run from roughly 60 to about 100, depending on how you count. The next wave is already in trials. Retatrutide, which acts on three hormone receptors, lost an average of 24.2% at 48 weeks in a phase two trial of 338 adults. In May 2026 Lilly reported 28.3% at 80 weeks on the highest dose in its first phase three trial (company-reported results). It is still not approved anywhere, and Lilly has said it plans to file with the FDA in the first quarter of 2027.
Worth sitting with. A trial result is an average. The 14.9% in STEP 1 means some people lost far more and some far less. When you see “average results”, ask what the spread looked like, and who is missing from the picture.
Why are most peptides injected?
Swallow a peptide and your digestive system treats it like food: enzymes chop it up. Reviews put the oral absorption of typical peptides at only a few percent. Even in the blood, enzymes and the kidneys clear them quickly. That is the main reason you see peptides as pens and vials. Capsules and creams are a different conversation, and we cover it in injections vs capsules and creams.
How long a peptide lasts shapes how often it is used. Our guide to peptide half-lives explains why some are weekly and others daily.
Three kinds of peptides worth keeping apart
- Approved medicines. Registered, well studied, prescribed by a doctor. Insulin and semaglutide are in this group.
- Food peptides. Collagen and whey peptides. They are food, the safety picture is well understood, and the effects are modest but real in some uses.
- Research compounds. Sequences still under investigation and not approved for human use. They are supplied for laboratory research, and the rules differ from country to country.
Most of the confusion, and most of the bad advice, comes from lumping these three together. “Peptides work” and “peptides are dodgy” are both close to meaningless. The useful question is always: which one, at what dose, studied in whom?
How to judge a peptide claim
- Was it studied in people? A lot of peptide research is still in cells or rodents. That is how nearly every medicine starts, but it is not proof it works in you.
- What dose, and how was it given? A peptide injected into a rodent’s tissue tells you very little about a capsule in a person.
- Compared to what? A before-and-after with no comparison group cannot separate the compound from time, placebo and everything else the person changed that month.
Want to go deeper? How to read a peptide study walks through it step by step.
If you are just starting out
You are not behind, and you do not need to learn it all tonight. Sleep, lifting, enough protein and some cardio beat any peptide, and they are worth sorting first. Peptides are a question to explore on top of that, not instead of it. In the STEP 1 follow-up, people who stopped semaglutide regained about two-thirds of the weight they had lost within a year, so a peptide works best when it helps you build habits you keep.
Worth sitting with. Peptides are signals, and so is how you live. Sleep, training and food all talk to your body’s messaging systems every day. Before asking what to add, it is worth asking what your current days are already saying.
When you are ready to look at specific compounds, the quiz takes about a minute and starts from what you want to change, not from a name you have half-heard.
We stock products from more than one of the three groups above, and every listing says which one it is, including its regulatory status and intended use. That is the most useful line on the page.
Further reading: Once you know what peptides are, the next question is who made yours. See own-label peptides vs established brands.
Frequently asked questions
What are peptides in simple terms?
Short chains of amino acids, the building blocks of protein. Your body uses them mainly as chemical messengers.
How do peptides work in the body?
A peptide fits a specific receptor on the surface of a cell, like a key in a lock. The receptor passes a signal inside, and the cell responds, for example by releasing a hormone or taking up sugar.
Why are peptides so popular right now?
Mostly because of GLP-1 drugs such as semaglutide and tirzepatide, which produced large average weight loss in big trials, and because newer peptides such as retatrutide are following. Better engineering also made peptides last longer in the body.
Are peptides the same as steroids?
No. Steroids are built from cholesterol and act inside cells. Peptides are chains of amino acids and mostly work by binding receptors on the cell surface.
Why are most peptides injected and not swallowed?
Digestive enzymes break most peptides down, and only a small share is absorbed from the gut. Injecting them avoids that, though some peptides are made in other forms for other jobs.
Are peptides safe?
It depends on which one. Approved peptide medicines have known safety profiles. Research compounds do not have the same human data behind them. Speak to a doctor before using anything, and be careful with product quality.
Sources
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 2021.
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 2022. Conference coverage.
- Jastreboff AM et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. New England Journal of Medicine, 2023.
- Eli Lilly TRIUMPH-1 topline results, 21 May 2026 (company-reported): coverage in AJMC. Filing plan: Pharmacy Times, July 2026.
- AAAS. Science’s 2023 Breakthrough of the Year: GLP-1 agonists.
- Review on GLP-1 half-life and semaglutide design. Frontiers in Endocrinology, 2019.
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022.
- Reviews of therapeutic peptides: specificity, potency and delivery challenges; counts of approved peptide drugs.
Everything we sell is supplied for research use only and is not a registered medicine. Nothing here is medical advice.
Next up: the peptide finder if you would rather start from a goal, peptide side effects, peptides vs supplements, and whether peptides are legal in South Africa.
Want it all on one page? The Peptides 101 cheat sheet covers the compounds, formats and storage at a glance.

